SSSanjeev Chaand Sharma

Sanjeev Chaand Sharma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sanjeev Chaand Sharma has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Peptides in Plastic Surgery

    by Hui X. Lau, Sanjeev C. Sharma

    Aims: Bioactive peptides are increasingly investigated as therapeutic adjuncts in plastic surgery. Despite increasing scientific, commercial, and patient interest, the current evidence base remains heterogeneous and predominantly preclinical. This review aimed to evaluate the current and emerging applications of peptides in plastic surgery, focusing on wound healing, reconstructive surgery, scar modulation, aesthetic practice, safety, regulation, and translational barriers. Methods: A narrative review was performed using PubMed, EMBASE, CENTRAL, Scopus, and Google Scholar from database inception to May 2026. Evidence was synthesized narratively and graded using the Oxford Centre for Evidence-Based Medicine (OCEBM) framework alongside clinical readiness. Results: Evidence was most mature in wound healing, where antimicrobial and regenerative peptides have progressed to phase II and early phase III trials, although regulatory approval for plastic surgical indications remains lacking. Scar modulation peptides have entered early clinical evaluation, and aesthetic peptides have accumulated modest human data. In contrast, reconstructive applications remain supported predominantly by preclinical evidence. Limitations included small sample sizes, heterogeneous outcome measures, short follow-up, and manufacturer-funded studies in the aesthetic literature. Translational barriers included short biological half-life, poor tissue penetration, regulatory uncertainty, and the lack of adequately powered randomized controlled trials with standardized outcome measures. Conclusions: Peptides show promise but currently lack robust clinical validation across plastic surgical domains. The disparity between commercially marketed claims and current evidence is particularly pronounced in aesthetic practice. Plastic surgeons should maintain a critically informed approach when counseling patients and are uniquely positioned to lead the trials required to establish the evidence base for broader adoption.

  • Erythropoietin and Soft Tissue Flap Survival: A Systematic Review

    by Sanjeev C Sharma, Jai P Ramchandani, Abdulrazak Abdulsalam, Hadyn K N Kankam

    Background: Erythropoietin (EPO) has emerging tissue‐protective roles, including anti‐apoptotic, anti‐inflammatory, and pro‐angiogenic effects. In reconstructive surgery, where flap necrosis remains a significant challenge, EPO has been investigated as an agent to enhance flap survival. Currently, no pharmacological agent has consistently improved flap survival, underscoring the need for novel therapeutics. Methods: A systematic review was conducted in accordance with PRISMA guidelines. PubMed, Embase, and CENTRAL databases were searched from inception to September 2025. Eligible studies investigated the effect of EPO on surgical flap survival in animal or human models compared with placebo/no treatment, reporting percentage flap necrosis. Secondary outcomes included perfusion, histological and molecular parameters, and safety. Results: Nine animal studies met the pre‐defined inclusion criteria (mice, n = 139; rats, n = 196) using random‐pattern dorsal, musculocutaneous, and TRAM flap models. All studies evaluated the effect of recombinant human EPO with a variety of different doses, routes, and time applications. Across all studies, EPO was associated with reduced flap necrosis versus controls, with the greatest benefit observed from short‐course, low‐dose peri‐operative regimes. High‐dose or prolonged schedules were less effective and occasionally detrimental. EPO improved perfusion (capillary density, arteriolar flow), enhanced microvascularity and tissue preservation, and upregulated vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS) with reduced oxidative stress. No thrombotic events or treatment‐related mortality were reported. Conclusion: EPO improves flap survival in experimental animal models. Short‐term, low‐dose preconditioning appears most effective, while higher doses raise safety concerns. Translation to clinical practice requires optimization of dosing strategies and rigorous clinical trials.

  • Unusual Vascular Anomalies in Plastic Surgery

    by Sanjeev Chaand Sharma, Andrea Jester, Ramesh Vidyadharan

    Introduction: Rare pediatric vascular tumors and malformations can be diagnostically and therapeutically challenging. They may present atypically, mimic more common conditions, or be life-threatening. Understanding of the various conditions, early recognition, and multidisciplinary management are essential for successful treatment. Methods: A retrospective review was performed of selected pediatric vascular anomaly cases managed at a tertiary referral center between March 2023 and August 2025. Cases were chosen based on diagnostic complexity, rarity, and the requirement for multidisciplinary and/or targeted systemic therapy. Case Presentation Summary: Five cases are presented: kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon, congenital hemangioma, generalized lymphatic anomaly, and PIK3CA-related overgrowth spectrum disorder presenting with multifocal osteolytic lesions and fractures. Diagnoses were established through radiologic, histopathologic, and targeted genetic and molecular testing. Management combined wound care and reconstruction with systemic therapies. Propranolol was used as first-line therapy in infantile hemangioma, corticosteroids and sirolimus were used in vascular tumors with hematological complications, and alpelisib was utilized in PIK3CA-related disease. Outcomes were variable but demonstrated significant symptomatic and functional improvement with good overall tolerance of systemic therapy. Conclusion: These cases highlight the heterogeneity of pediatric vascular anomalies and their potential to mimic nonvascular pathology. Hand and plastic surgeons play a key role in recognition, biopsy, wound care and reconstruction, and rehabilitation within multidisciplinary teams. Novel targeted systemic therapies, such as sirolimus and alpelisib, alongside more traditional agents, including propranolol and corticosteroids, are central where surgery alone is inadequate. Awareness of these rare vascular anomalies is essential for timely diagnosis and treatment.

  • Top Cited Papers
    Open Access

    ChatGPT in Plastic and Reconstructive Surgery

    by Sanjeev Chaand Sharma, Jai Parkash Ramchandani, Arjuna Thakker, Anindya Lahiri

    Background Chat Generative Pre-Trained Transformer (ChatGPT) is a versatile large language model-based generative artificial intelligence. It is proficient in a variety of tasks from drafting emails to coding to composing music to passing medical licensing exams. While the potential role of ChatGPT in plastic surgery is promising, evidence-based research is needed to guide its implementation in practice. Methods This review aims to summarize the literature surrounding ChatGPT's use in plastic surgery. Results A literature search revealed several applications for ChatGPT in the field of plastic surgery, including the ability to create academic literature and to aid the production of research. However, the ethical implications of using such chatbots in scientific writing requires careful consideration. ChatGPT can also generate high-quality patient discharge summaries and operation notes within seconds, freeing up busy junior doctors to complete other tasks. However, currently clinical information must still be manually inputted, and clinicians must consider data privacy implications. Its use in aiding patient communication and education and training is also widely documented in the literature. However, questions have been raised over the accuracy of answers generated given that current versions of ChatGPT cannot access the most up-to-date sources. Conclusions While one must be aware of its shortcomings, ChatGPT is a useful tool for plastic surgeons to improve productivity for a range of tasks from manuscript preparation to healthcare communication generation to drafting teaching sessions to studying and learning. As access improves and technology becomes more refined, surely more uses for ChatGPT in plastic surgery will become apparent.


  • Nerve wrapping for recurrent compression neuropathy: A systematic review

    by Arjuna Thakker, Sanjeev Chaand Sharma, Niha Mariam Hussain, Pooja Devani, Anindya Lahiri


  • Open Access

    Revolution in UK General Practice Due to COVID-19 Pandemic: A Cross-Sectional Survey

    by Sanjeev C. Sharma, Sonita Sharma, Arjuna Thakker, Gopal Sharma, Mohamed Roshan, Vivek Varakantam

    To assess how UK General Practitioners (GPs) and Practice Managers (PMs) have coped with the challenges posed by the coronavirus disease-19 (COVID-19) pandemic and whether they felt adequately supported by the wider National Health Service (NHS). This is a cross-sectional survey. All GPs and PMs (total 1,354) in Leicester, Leicestershire, and Rutland (LLR) were invited to participate in an online questionnaire. A total of 95 invitees completed the survey. Over a quarter had required time off work due to COVID symptoms or contact. All respondents described either introducing or increasing the use of remote patient consultations. Most striking was the rise in video consultations from just 3% to 95% during the pandemic. Almost half of the feedback on the usefulness of remote consultations were positive, 16% were negative and 17% were mixed. The most commonly cited benefit was time efficiency. Drawbacks of remote consultations included technical difficulties and poor patient communication. Practice premises, systems and processes also required significant modifications during the pandemic to ensure the provision of safe clinical care, including reception screens, one-way patient flow, greater infection prevention measures. However, despite their ability to introduce such widescale change virtually overnight, over 10% of respondents reported that the strain had placed their practice at risk of closure. Over half of respondents felt they were not provided with adequate personal protective equipment (PPE) for the safety of their staff. Perception of the support provided by NHS England and the Clinical Commissioning Groups (CCGs) was rather mixed, although additional guidelines were broadly welcomed. The most requested enduring changes related to remote patient consultations (59%) and remote triage (19%). However, in order to support such largescale permanent change, study respondents felt that a different funding and financial structure is required together with improved IT infrastructure, greater patient education and a more supportive regulatory environment. COVID-19 has substantially accelerated the pace of change within NHS primary care. The long-term fear is that there may be insufficient financial and clinical backing from regulatory bodies to support such rapid and far-reaching changes.